As none of these combinations with pazopanib are currently approved by the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA), only dedicated pharmacokinetic interaction studies will be discussed in detail in this review. To study the potential of pazopanib for drug–drug...
Severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff muscles, high fever, profuse sweating, or tremors. This document does not contain all possible side effects and others may occur. Check with your physician for addi...